Showing results (31-40 of 105) with videos related to
Sort By:
Pageof 11
Investigational New Drugs|February 19, 2011
Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcomaSteven J O'Day, Anna C Pavlick, Mark R Albertini, et al.Anti-Cancer Drugs|April 13, 2004
A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factorAnna C Pavlick, Catherine Chodkiewicz, Leonard Liebes, et al.Journal of Neuro-Oncology|April 13, 2013
Vemurafenib and radiation therapy in melanoma brain metastasesAshwatha Narayana, Maya Mathew, Moses Tam, et al.Pathology, Research and Practice|October 20, 2024
Whole genome sequencing elucidates etiological differences in MCPyV-negative Merkel cell carcinomaCarla Stephan, Majd Al Assaad, Max F Levine, et al.The Journal of Molecular Diagnostics : JMD|March 27, 2007
Detection of mutant BRAF alleles in the plasma of patients with metastatic melanomaMolly Yancovitz, Joanne Yoon, Maryann Mikhail, et al.Journal of Cancer|October 6, 2025
Phase 1b Study of Tovorafenib, Plozalizumab or Vedolizumab Plus Standard-of-Care Immune Checkpoint Inhibitors in Patients with Advanced MelanomaRyan J Sullivan, Katy K Tsai, Anna C Pavlick, et al.Cancer|July 11, 2007
Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanomaMolly Yancovitz, Nika Finelt, Melanie A Warycha, et al.Journal of Community Health|November 17, 2010
Impact of socioeconomic status and sociodemographic factors on melanoma presentation among ethnic minoritiesLindsay G Wich, Michelle W Ma, Leah S Price, et al.Cancer|November 7, 2008
Changes in the presentation of nodular and superficial spreading melanomas over 35 yearsMelanie A Warycha, Paul J Christos, Madhu Mazumdar, et al.Cancer Chemotherapy and Pharmacology|October 16, 2012
Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trialPatrick A Ott, Jason Chang, Kathleen Madden, et al.Pageof 11